The pharmaceuticals in dosage market in Vietnam has demonstrated a dynamic growth trend from 2012 to 2022, with fluctuations in year-on-year variations and compound annual growth rates (CAGR). The market size grew from $3.7352 billion in 2012 to $5.7773 billion in 2022. From 2018 onward, the market experienced some instability with a notable drop in 2018 (-3.26%) and another decline in 2022 (-6.63%). Despite these variations, a notable surge was observed in 2021 with a 13.3% increase. Over the last five years, the average annual growth rate (CAGR) stood at a modest 1.93%.
Future trends to watch for include the impact of healthcare reforms, increased investment in healthcare infrastructure, growing demand for generic drugs, and the potential influence of international trade policies. Enhanced focus on innovation, coupled with the integration of advanced technologies in pharmaceuticals, is likely to drive market growth further in coming years.
How does Vietnam rank in Pharmaceuticals in Dosage Market Size Value?
| # | 59 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 110,040,000,000 | 2023 | -0.57% | +2.9% | View data |
| 2 | 2 Japan | 102,270,000,000 | 2023 | +1.29% | +1.27% | View data |
| 3 | 3 Italy | 90,420,000,000 | 2023 | -0.45% | +3.03% | View data |
| 4 | 4 France | 70,241,000,000 | 2023 | -2.11% | -1.64% | View data |
| 5 | 5 United Kingdom | 69,574,000,000 | 2023 | -0.43% | -2.13% | View data |
| 16 | 16 Denmark | 7,672,000,000 | 2023 | -0.099% | -1.22% | View data |
| 17 | 17 South Africa | 7,094,600,000 | 2023 | +0.59% | -1.14% | View data |
| 18 | 18 Vietnam | 6,321,600,000 | 2023 | +4.48% | +4.47% | |
| 19 | 19 Portugal | 6,033,800,000 | 2023 | -2.53% | -4.53% | View data |
| 20 | 20 Norway | 5,951,900,000 | 2023 | +1.05% | -0.35% | View data |
